Tirzepatide Associated With Lower Risk of Diabetic Retinopathy Progression and Treatment
A retrospective study published in Ophthalmology indicates that patients with diabetes who take tirzepatide show a lower risk of diabetic retinopathy progression compared to those using lifestyle interventions alone. While the findings are promising, researchers emphasize that the study shows an association rather than direct causation.
Patients with diabetes who initiated tirzepatide had lower rates of diabetic retinopathy, vision-threatening complications, and retinal interventions than matched patients receiving lifestyle intervention alone, according to a large retrospective study published in Ophthalmology. 1
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in